ICER: FDA failed to protect patients from unproven Alzheimer’s treatment with known harms
(Natural News) The Food and Drug Administration (FDA) drew criticisms after granting Alzheimer’s disease drug Aduhelm a conditional approval. It allows the drug scientifically known as aducanumab to be prescribed…